ABVC BioPharma 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABV-1504 / ABVC BioPharma
NCT05202327: PDC-1421 Treatment in Adult Patients With ADHD

Completed
2
70
US, RoW
PDC-1421 Capsule, Extract of Radix Polygalae, Placebo, Corn Starch
BioLite, Inc., ABVC BioPharma, Inc
Attention-Deficit Hyperactivity Disorder (ADHD)
12/23
12/23
NCT03833206: A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Not yet recruiting
1/2
12
US
PDC-1421 Capsule
BioLite, Inc., American BriVision Corporation
Major Depressive Disorder
02/27
02/27
Foscan (temoporfin) / ABVC BioPharma
2004-004452-39: Photodynamic therapy as palliative treatment for recurrent squamous cell carcinom of the head and neck region

Ongoing
2
50
Europe
Foscan (Temoporfin), Foscan, Foscan
Christel B. Lajer, Dep. of Otolaryngology head and neck surgery, Rigshospitalet
Recurrent squamous cell carcinoma of the head and neck Region
 
 
NCT03003065: Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers

Completed
2
10
RoW
Temoporfin, Foscan
Chinese University of Hong Kong
Cholangiocarcinoma, Tumor, Klatskin Tumor
04/23
08/23
RGC-1501 / ABVC BioPharma, Rgene Corp
NCT05764928: Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Not yet recruiting
1/2
32
RoW
BLEX 404
Rgene Corporation, American BriVision Corporation
Nonsquamous Nonsmall Cell Neoplasm of Lung
12/27
12/27
RGC-1502 / ABVC BioPharma, Rgene Corp
NCT03301805: A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Not yet recruiting
2
40
NA
BLEX 404
Rgene Corporation, American BriVision Corporation
Pancreatic Cancer
04/27
06/27
ABV-1501 / ABVC BioPharma
NCT02802423: Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

Not yet recruiting
1/2
44
NA
BLEX 404 Oral Liquid
BioLite, Inc.
Triple Negative Breast Cancer
04/27
08/27
ABV-1702 / ABVC BioPharma
NCT02944955: A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Not yet recruiting
2
52
NA
BLEX 404 Oral Liquid
BioLite, Inc.
Myelodysplastic Syndrome (MDS)
12/27
06/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABV-1504 / ABVC BioPharma
NCT05202327: PDC-1421 Treatment in Adult Patients With ADHD

Completed
2
70
US, RoW
PDC-1421 Capsule, Extract of Radix Polygalae, Placebo, Corn Starch
BioLite, Inc., ABVC BioPharma, Inc
Attention-Deficit Hyperactivity Disorder (ADHD)
12/23
12/23
NCT03833206: A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

Not yet recruiting
1/2
12
US
PDC-1421 Capsule
BioLite, Inc., American BriVision Corporation
Major Depressive Disorder
02/27
02/27
Foscan (temoporfin) / ABVC BioPharma
2004-004452-39: Photodynamic therapy as palliative treatment for recurrent squamous cell carcinom of the head and neck region

Ongoing
2
50
Europe
Foscan (Temoporfin), Foscan, Foscan
Christel B. Lajer, Dep. of Otolaryngology head and neck surgery, Rigshospitalet
Recurrent squamous cell carcinoma of the head and neck Region
 
 
NCT03003065: Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers

Completed
2
10
RoW
Temoporfin, Foscan
Chinese University of Hong Kong
Cholangiocarcinoma, Tumor, Klatskin Tumor
04/23
08/23
RGC-1501 / ABVC BioPharma, Rgene Corp
NCT05764928: Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

Not yet recruiting
1/2
32
RoW
BLEX 404
Rgene Corporation, American BriVision Corporation
Nonsquamous Nonsmall Cell Neoplasm of Lung
12/27
12/27
RGC-1502 / ABVC BioPharma, Rgene Corp
NCT03301805: A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Not yet recruiting
2
40
NA
BLEX 404
Rgene Corporation, American BriVision Corporation
Pancreatic Cancer
04/27
06/27
ABV-1501 / ABVC BioPharma
NCT02802423: Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

Not yet recruiting
1/2
44
NA
BLEX 404 Oral Liquid
BioLite, Inc.
Triple Negative Breast Cancer
04/27
08/27
ABV-1702 / ABVC BioPharma
NCT02944955: A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Not yet recruiting
2
52
NA
BLEX 404 Oral Liquid
BioLite, Inc.
Myelodysplastic Syndrome (MDS)
12/27
06/28

Download Options